Leap Therapeutics, Inc. - Common Stock (NQ:LPTX)

2.060 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Leap Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 17, 2023

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 17, 2023

Via Benzinga

Leap Therapeutics Shares Fall After Flame Biosciences Acquisition ↗

January 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 08, 2022

Gainers

Via Benzinga

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗

November 09, 2022

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 12, 2022

Via Benzinga

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

May 31, 2022

Gainers Performance Shipping Inc. (NASDAQ: PSHG) rose 41.7% to $ 0.94 in pre-market trading. Performance Shipping shares dipped around 64% on Friday after the company announced the pricing of an...

Via Benzinga

110 Biggest Movers From Friday ↗

May 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Via Benzinga

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China ↗

March 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In...

Via Benzinga

Leap Therapeutics: Q4 Earnings Insights ↗

March 11, 2022

Leap Therapeutics (NASDAQ:LPTX) reported its Q4 earnings results on Friday, March 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 04, 2022

Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...

Via Benzinga

48 Biggest Movers From Yesterday ↗

January 21, 2022

Gainers Aptorum Group Limited (NYSE: APM) shares jumped 38.5% to close at $1.69 on Thursday after the company announced it received FDA Orphan Drug designation for...

Via Benzinga

Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer

January 20, 2022

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to...

Via FinancialNewsMedia

Topics Death

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 19, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR)...

Via Benzinga

35 Stocks Moving In Wednesday's Mid-Day Session ↗

January 19, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion. Splash Beverage Group,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...

Via Benzinga

The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data ↗

January 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 19, 2022

Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients ↗

January 19, 2022

Leap Therapeutics Inc (NASDAQ: LPTX) will present updated data from the DisTinGuish Phase 2a study of DKN-01, in combination with tislelizumab in gastric or gastric...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2021 ↗

October 04, 2021

Upgrades According to Raymond James, the prior rating for Roper Technologies Inc (NYSE:

Via Benzinga

Looking Into Leap Therapeutics's Return On Capital Employed ↗

October 01, 2021

Benzinga Pro data, Leap Therapeutics (NASDAQ:LPTX) reported Q2 sales of $375.00 thousand. Earnings fell to a loss of $9.63 million, resulting in a 4.95% decrease from last...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

51 Biggest Movers From Yesterday ↗

October 01, 2021

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...

Via Benzinga

3 Penny Stocks Insiders Are Buying ↗

September 29, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data ↗

September 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.